Author:
Wang Shuibang,Dougherty Edward J.,Danner Robert L.
Funder
National Institutes of Health intramural funds
Reference138 articles.
1. The worldwide epidemiology of type 2 diabetes mellituspresent and future perspectives;Chen;Nat. Rev. Endocrinol.,2012
2. Thiazolidinediones;Yki-Jarvinen;N. Engl. J. Med.,2004
3. Studies on antidiabetic agents II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives;Sohda;Chem. Pharm. Bull. (Tokyo),1982
4. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent;Fujita;Diabetes,1983
5. Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats;Fujiwara;Diabetes,1988
Cited by
139 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献